OncoCyte Corporation (OCX) Gained 7.25% or 0.24 To Price $3.55 On Thursday


OncoCyte Corporation (OCX) gained 7.25% or 0.24 to $3.55. It is near to 521570 shares traded, which is 20.88% compare to the average total volume 2.50 million. The market cap of OCX is $184.50 million. The year to date change is 132.42%. The 52 week price range is from $1.1 to $6.92. Price of OCX have changed -0.30% during last week. It have changed -23.02% over last month, 108.18% over last 3 months, 37.92% over last 6 months and 10.33% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for OCX is 2.87. It is -19.15% below current price. The 200-day Moving Averages for OCX is 2.46. It is -30.70% below current price. The 52-week High is 6.92. It is 94.93% from the current price. The 52-week Low is 1.1. It is -69.01% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of OCX is 0.31 on 2019-02-15. Short % to float is 1.94%. There are some statistics of OCX. It is has market cap $184.50 million. The share outstanding is 51.97 million. The average volume is 2.50 million. The percent of top 15 Institution holding is 18.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of OCX is -195.41%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of OCX is -112.06%.


Tags:

Share this post